Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

Status:
Completed

Trial end date:
2003-08-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.

Phase 2

Telik